Ross Soo, MBBS, PhD, FRACP / Jonathan D. Spicer, MD, PhD, FRCSC - The Power of Personalised: Unlocking the Secrets of Individualised Management of Resectable EGFRm NSCLC

About this episode

The episode discusses personalized management strategies for resectable EGFRm NSCLC, featuring insights from leading experts in the field.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/BVV865. CME credit will be available until 9 April 2027. The Power of Personalised: Unlocking the Secrets of Individualised Management of Resectable EGFR m NSCLC In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an independent educational grant from AstraZeneca. Disclosure information is available at the beginning of the video presentation.

People in this episode

Guests: Ross Soo, MBBS, PhD, FRACP, Jonathan D. Spicer, MD, PhD, FRCSC

Topics covered

• personalized medicine
• EGFRm NSCLC
• healthcare education
• patient care
• continuing medical education

Keywords

• personalized management
• EGFR mutation
• NSCLC
• healthcare professionals
• CME credit

Sponsors

AstraZeneca

Mentioned in this episode

Organizations: PeerView Institute for Medical Education, Accreditation Council for Continuing Medical Education, Accreditation Council for Pharmacy Education, American Nurses Credentialing Center

More episodes of PeerView Oncology & Hematology CME/CNE/CPE Video Podcast

• Andrew Kuykendall, MD - Ironing Out the Challenges of PV: Spotlight on Targeting the Hepcidin Pathway for Addressing Unmet Needs and Enhancing Patient Outcomes · June 5, 2026 · 32 min
• Brendon M. Stiles, MD - The Immunotherapy Playbook for Resectable NSCLC: Real-World Challenges and Practical Strategies · June 4, 2026 · 1h 6m
• Luke Maese, DO, Rachel Rau, MD - ADAPT to Advance in ALL/LBL: Achieving Durable Asparaginase Exposure With Personalized Treatment in Pediatric and AYA Patients · May 29, 2026 · 49 min
• Charise Gleason, MSN, NP-C, AOCNP / Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO - “Off-the-Shelf” Choices in RRMM: Oncology Nurse Guidance on Delivering Quality Care With BCMA and Non-BCMA Immunotherapy · May 29, 2026 · 60 min
• Jaume Capdevila, MD, PhD - Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings · May 29, 2026 · 55 min
• Amy E. Armstrong, MD, Angela Hirbe, MD, PhD - ReiNForcing Care Pathways in NF1-PN: Solutions to Improve Outcomes Across the Patient Journey With MEK Inhibition and Shared-Care Models · May 29, 2026 · 1h 5m